Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
Status:
Recruiting
Trial end date:
2024-06-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is evaluating the efficacy and safety of SC antifrolumab in adult
patients with moderate -to-severe SLE despite receiving standard therapy